MAIA Stock Analysis: Buy, Sell, or Hold?
MAIA - MAIA Biotechnology, Inc.
$1.35
-0.04 (-2.88%)
âŧ
5d:
-2.88%
30d:
+8.87%
90d:
+5.47%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When MAIA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MAIA is fairly priced but lacks strong directional signals. At 10.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MAIA is fairly priced but lacks strong directional signals. At 10.9% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$1.40
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$0.87
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MAIA is currently trading at $1.35, which is considered fair relative to its 30-day fair value range of $1.27 to $1.40. From a valuation perspective, the stock is trading at a premium (Forward PE: 1.2) compared to its historical average (0.9). At these levels, the market is pricing in 10.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MAIA is in a strong downtrend. The price is currently testing key support at $1.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MAIA scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+788.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MAIA is in a strong downtrend. The price is currently testing key support at $1.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MAIA scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+788.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.27 -
$1.40
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
49.0%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 788.9% below Wall St target ($12.00)
- NEUTRAL: Trading at premium valuation - market expects 10.9% growth which is achievable
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.27 -
$1.40
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.33
Resistance Level
$1.42
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1.22
Wall Street Target
$12.00
(+788.9%)
Valuation Premium vs History
+10.9% premium
PE vs Historical
1.2 vs 0.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+10.9%
(market-implied from PE analysis)
1-Year Target
$1.50
(+11%)
2-Year Target
$1.66
(+23%)
3-Year Target
$1.84
(+36%)
3-Yr Target (if PE normalizes)
(PE: 1â1)
PE COMPRESSION
$1.36
(+1%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: August 24, 2026 6:02 PM ET
Data refreshes hourly during market hours. Next update: 7:02 PM
Data refreshes hourly during market hours. Next update: 7:02 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MAIA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 46 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 45 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 68 BUY |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
BUY
20 analysts |
$34 | 47 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
13 analysts |
$19 | 51 HOLD |
